# Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation

> **NCT01432743** · PHASE2 · COMPLETED · sponsor: **Barts & The London NHS Trust** · enrollment: 101 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** NavX Fusion
- **PROCEDURE:** Cartomerge

## Key facts

- **NCT ID:** NCT01432743
- **Lead sponsor:** Barts & The London NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2011-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432743, "Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01432743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*